Gastrointestinal Lymphoproliferative Lesions: a Practical Diagnostic Approach
Overview
Affiliations
The gastrointestinal tract (GI) is the primary site of lymphoproliferative lesions, spanning from reactive lymphoid hyperplasia to overt lymphoma. The diagnosis of these diseases is challenging and an integrated approach based on clinical, morphological, immunohistochemical and molecular data is needed. To reach to confident conclusions, a stepwise approach is highly recommended. Histological evaluation should first assess the benign neoplastic nature of a given lymphoid infiltrate. Morphological and phenotypic analyses should then be applied to get to a definite diagnosis. This review addresses the key histological features and diagnostic workup of the most common GI non-Hodgkin lymphomas (NHLs). Differential diagnoses and possible pitfalls are discussed by considering distinct groups of lesions ( small to medium B-cell NHLs; medium to large B-cell NHLs; T-cell NHLs; and mimickers of Hodgkin lymphoma). The key clinical and epidemiological features of each entity are also described.
Fan Y, Thong B, Binshen O, Shen X, Yi H, Wang C Int J Immunopathol Pharmacol. 2024; 38:3946320241264369.
PMID: 38886178 PMC: 11185012. DOI: 10.1177/03946320241264369.
Intestinal T-cell lymphoma not otherwise specified: a case report and literature review.
Laabidi S, Hamouga R, Bouslama S, Sellami R, Shimi S, Labidi A Future Sci OA. 2024; 10(1):FSO942.
PMID: 38817379 PMC: 11137769. DOI: 10.2144/fsoa-2023-0119.
Zhang B, Zou M, Lu Z, Mao H, Huang Y, Liu F Front Oncol. 2021; 11:694934.
PMID: 34956855 PMC: 8695756. DOI: 10.3389/fonc.2021.694934.
Covelli C, Parente P, Trombetta D, Graziano P BMJ Case Rep. 2021; 14(7).
PMID: 34285036 PMC: 8292813. DOI: 10.1136/bcr-2021-244643.